Rational Drug Design Software News
By: David Bradley
You can now search the open access chemical literature direct through the ChemSpy search engine (in association with ChemRefer) The search box provides access to almost every chemistry paper that is freely available online.
03/29/2006
Those in the bio research arena will no doubt have come across NIH's PubChem system already. It's basically the small molecule version of PubMed, allowing you to search out all kinds of information about small molecules, pharmaceuticals, and ligands. Now, SB partner site Chemspy provides direct access to PubChem searching as well as searching of the Open Access chemistry literature through the Chemrefer dialog on the Chemspy home page
03/24/2006
Pharma & Bio Ingredients is devoted exclusively to the formulation needs of the pharmaceutical and biopharmaceutical chemist. Each issue of Pharma & Bio Ingredients will include in-depth articles on topics such as large- and small-molecule drug discovery, excipients, scale-up, sourcing and patents. All of them are designed to help pharma and biopharma R&D personnel complete their jobs better and faster than ever before. In addition, Pharma & Bio Ingredients will include columns from industry experts on such topics as trials and filings, regulations and international news. http://sciencebase.tradepub.com/free/pbi/prgm.cgi (USA, international (digital only)
02/28/2006
Readers in North America can qualify for a free annual subscriptioon to Chain Drug Review, the premier source for timely industry news and in-depth product category analyses. This hard-hitting magazines provides thorough coverage of vital industry concerns, squarely confronting the challenges of the chain drug industry.
02/17/2006
Grab a free subscription to the leading biotech industry email newsletter, Fierce Biotech. Offer extended for one more week.
02/16/2006
Get the skinny on the biotech industry - FREE
01/12/2006
Bird flu is heading west, should you be concerned and is there a rational drug approach to take?
01/10/2006
Various companies offer unique solutions for common problems in biomolecular modelling: Molecular file format problems, Force field and energy calculation problems, Computational resource problems, Visualization problems. They employ the latest leading edge technology to provide the above solutions with the highest quality and performance possible. For more details on the methods applied contact us.
03/29/2006
Hail CAESA - Computational techniques to automatically generate large sets of structures are becoming increasingly widespread and methods for automatically prioritizing structures are becoming central to the effective application of structure generation programs for practical problem solving. Now, CAESA (Computer Assisted Estimation of Synthetic Accessibility) provides users with the ability to rank automatically sets of molecules according to how easy they will be to synthesise. Read the Sciencebase review.
03/29/2006
Who is your software partner for rational drug design. Companies with many years of development experience and various computational chemistry applications are around, send us your hints and tips on how to narrow down the search. Do you need expertise in molecular docking (flexible ligand docking & fast pre-docking), pharmacophore modelling, 3D database search, de novo design, expert 3D visualizations techniques, designing large software systems and designing rapid application development? Let us know.
03/29/2006
Unique solutions for common problems in biomolecular modelling are available from numerous drug discovery companies. Molecular file format problems, force field and energy calculation problems, computational resource problems, visualization problems. Most employ the latest cutting edge technology to provide solutions with the highest quality and performance possible.
03/29/2006
Click here for more information about our RSS latest science news and how
to view and subscribe to RSS blogs.
If you would like us to render your RSS specialist newsfeed on the
sciencebase site and so benefit from our targeted audience, please get in
touch to discuss how we can work together.



Nature Reviews Drug Discovery